Boston’s Longwood medical hub; oldest US medical school powerhouse
Researchers have examined brains from 235 former NFL players who died between 2016 and 2021 and have confirmed chronic traumatic encephalopathy (CTE) in 215. Including all 878 players who died in that period, the team has calculated a conservative minimum prevalence of CTE of 24.5% at death and urged prevention to cut repetitive head impacts.
Canada has announced a government-backed program to hire 64 researchers, with 48 coming from the United States, including Harvard and MIT, to join Canadian universities. The initiative, funded with over C$500 million, aims to bolster fields from climate science to artificial intelligence as tensions with the US influence academic mobility. The shift follows policy crackdowns in the United States and a broader tradewar backdrop.
Investors have pushed new biotech winners — from Novo Nordisk’s semaglutide pill to startups tackling baldness and targeted autoimmune drugs — while market enthusiasm has cooled for some forecasts. Novo Nordisk has released a daily weight‑loss pill used by over 1.5 million people; hair‑loss startups have sent small caps soaring; India’s low‑cost GLP‑1 generics have underperformed expectations.
New pieces from Independent and New York Post highlight cognitive health strategies: handwriting may strengthen memory, while social activity and ongoing mental stimulation could delay dementia. Experts advise starting early and reducing passive screen time.
Lawsuits allege GLP-1 diabetes drugs may cause nonarteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause permanent vision loss. Novo Nordisk and Eli Lilly dispute the claims as regulators review data; meanwhile trials and studies show mixed signals about risk.
Anthropic has expanded its biology lab in San Francisco and bought Coefficient Bio to explore AI-assisted biotech. Leaders say real-life lab work is essential to testing AI-driven theories, while the company faces pushback from customers and industry observers over potential competition and safety concerns.
An AP-KFF poll finds that rural voters are divided on whether President Donald Trump's sweeping immigration crackdown has benefited or harmed their communities.
The FDA has required makers of GLP‑1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, to add a warning about a rare eye condition called non‑arteritic anterior ischemic optic neuropathy (NAION). The agency has found a small increased risk in trial and real‑world data and is urging patients with sudden, painless vision loss in one eye to seek prompt ophthalmology evaluation.